The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD

Abstract Background Diabetic kidney disease is the leading cause of end-stage renal disease and is associated with increased morbidity and mortality. This review is an authorized literal translation of part of the Brazilian Diabetes Society (SBD) Guidelines 2021–2022. This evidence-based guideline p...

Full description

Bibliographic Details
Main Authors: João Roberto de Sá, Erika Bevilaqua Rangel, Luis Henrique Canani, Andrea Carla Bauer, Gustavo Monteiro Escott, Themis Zelmanovitz, Marcello Casaccia Bertoluci, Sandra Pinho Silveiro
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Diabetes mellitus
Diabetic kidney disease
Diabetic nephropathy
Management
Treatment
Online Access:https://doi.org/10.1186/s13098-022-00843-8

Internet

https://doi.org/10.1186/s13098-022-00843-8

Similar Items